Stock Price
2.16
Daily Change
-0.03 -1.37%
Monthly
-51.89%
Yearly
-22.86%
Q2 Forecast
2.12

Acasti Pharma reported $-4.76M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Acasti Pharma USD -4.76M 4.76M Dec/2024
Addus HomeCare USD 363.6M 9.5M Mar/2026
Amarin USD 49.22M 451K Dec/2025
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Option Care Health USD 1.35B 120M Mar/2026
Organigram Holdings CAD 63.54M 16.52M Dec/2025
Tilray USD 217.51M 74.75M Dec/2025